Education
About Us
Working with TipRanks
Follow Us
Generation Bio Co. (GBIO)
NASDAQ:GBIO
GBIO Analyst Ratings
Moderate Buy
2 Buy
4 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
GBIO Stock 12 Month Forecast
Average Price Target
$10.13
▲(53.25% Upside)
| Highest Price Target$15.00 | Average Price Target$10.13 | Lowest Price Target$6.50 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Citizens JMP
―
Hold
―
Reiterated
08/14/25
TR | OpenAI - 4o
$4.5→$6.5
Hold
-1.66%
Downside
Reiterated
08/14/25
Wedbush
$7
Hold
5.90%
Upside
Downgraded
08/13/25
Jefferies
$40→$12
Buy
81.54%
Upside
Reiterated
08/13/25
Needham
$15
Buy
126.93%
Upside
Reiterated
08/13/25
Generation Bio's Promising siRNA Delivery and Financial Stability Justify Buy Rating Despite Workforce Reductions1:12 PM 2025 PRICE TARGET & ESTIMATE CHANGE Biotechnology Generation Bio Co. (GBIO) RATING BUY PRICE TARGET $15.00 PREV CLOSE $4.05 52-WEEK RANGE $3.00 - $29.40 2Q:25 Update; Generation Seeking Strategic Alternatives Generation reported 2Q:25 financial results yesterday and announced it will be reducing its headcount by ~90% over the next several months as it explores strategic alternatives to maximize shareholder value. We maintain our Buy Rating but are lowering our Target to $15 due to increased uncertainty around the company's path forward and potential ability to secure additional funding. Recent preclinical data showed Generation's ctLNPs successfully achieved selective delivery of siRNA to T-cells in NHPs. No safety signals were reported after single or multiple doses.
TD Cowen
―
Hold
―
Reiterated
08/12/25
Canaccord Genuity
$90
Buy
1261.57%
Upside
Reiterated
03/14/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Citizens JMP
―
Hold
―
Reiterated
08/14/25
TR | OpenAI - 4o
$4.5→$6.5
Hold
-1.66%
Downside
Reiterated
08/14/25
Wedbush
$7
Hold
5.90%
Upside
Downgraded
08/13/25
Jefferies
$40→$12
Buy
81.54%
Upside
Reiterated
08/13/25
Needham
$15
Buy
126.93%
Upside
Reiterated
08/13/25
Generation Bio's Promising siRNA Delivery and Financial Stability Justify Buy Rating Despite Workforce Reductions1:12 PM 2025 PRICE TARGET & ESTIMATE CHANGE Biotechnology Generation Bio Co. (GBIO) RATING BUY PRICE TARGET $15.00 PREV CLOSE $4.05 52-WEEK RANGE $3.00 - $29.40 2Q:25 Update; Generation Seeking Strategic Alternatives Generation reported 2Q:25 financial results yesterday and announced it will be reducing its headcount by ~90% over the next several months as it explores strategic alternatives to maximize shareholder value. We maintain our Buy Rating but are lowering our Target to $15 due to increased uncertainty around the company's path forward and potential ability to secure additional funding. Recent preclinical data showed Generation's ctLNPs successfully achieved selective delivery of siRNA to T-cells in NHPs. No safety signals were reported after single or multiple doses.
TD Cowen
―
Hold
―
Reiterated
08/12/25
Canaccord Genuity
$90
Buy
1261.57%
Upside
Reiterated
03/14/25
Best Analysts Covering Generation Bio
1 Month
xxx
Success Rate
8/22 ratings generated profit
Average Return
-7.94%
reiterated a xxx
rating 2 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 36.36% of your transactions generating a profit, with an average return of -7.94% per trade.
3 Months
xxx
Success Rate
8/22 ratings generated profit
Average Return
-16.01%
reiterated a xxx
rating 2 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 36.36% of your transactions generating a profit, with an average return of -16.01% per trade.
1 Year
2 Years
xxx
Success Rate
2/22 ratings generated profit
Average Return
-63.52%
reiterated a xxx
rating 2 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 9.09% of your transactions generating a profit, with an average return of -63.52% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
GBIO Analyst Recommendation Trends
Rating
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Strong Buy
6
6
3
2
2
Buy
0
0
0
0
0
Hold
4
5
8
13
14
Sell
2
2
2
2
0
Strong Sell
0
0
0
0
0
total
12
13
13
17
16
Each month's total comprises the sum of three months' worth of ratings.
GBIO Financial Forecast
GBIO Stock Forecast FAQ
What is GBIO’s average 12-month price target, according to analysts?
Based on analyst ratings, Generation Bio Co.’s 12-month average price target is 10.13.
What is GBIO’s upside potential, based on the analysts’ average price target?
Generation Bio Co. has 53.25% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is GBIO a Buy, Sell or Hold?
Generation Bio Co. has a consensus rating of Moderate Buy which is based on 2 buy ratings, 4 hold ratings and 0 sell ratings.
What is Generation Bio Co.’s price target?
The average price target for Generation Bio Co. is 10.13. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $15.00 ,the lowest forecast is $6.50. The average price target represents 53.25% Increase from the current price of $6.61.
The highest analyst price target is $15.00 ,the lowest forecast is $6.50. The average price target represents 53.25% Increase from the current price of $6.61.
What do analysts say about Generation Bio Co.?
Generation Bio Co.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 6 Wall Streets Analysts.
How can I buy shares of GBIO?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.